Drug Plan Management, Prescription Drugs Canadian Insurer details on coverage for Wegovy for cardiovascular treatment February 1, 2025 GroupForce Benefit News January 2025 Tags: Canada, Cardiovascular indication, Insurance, semaglutide, Wegovy, weight loss What do you think? Show comments / Leave a comment Insights More Related Articles Advise, Healthcare, Prescription Drugs, The Workplace The here and now of pharmacogenetic testing Media 2025 Canadian Leadership Council on Drug Plan Partnerships Advise, The Workplace e2r Blog Post Alerts – Sick Notes
